Harvard Bioscience, Inc.
05 Aug 2015
Available for Immediate Download
Harvard Bioscience, Inc. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Harvard Bioscience, Inc. required for business and competitor intelligence needs - Intelligence on Harvard Bioscience, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Harvard Bioscience, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Harvard Bioscience, (Harvard) is a developer, manufacturer and marketer of a broad range of scientific instruments, primarily apparatus and scientific instruments used for advance life science research at pharmaceutical and biotechnology companies, universities, and government laboratories globally. The company operates in the US, the UK, France, Spain, Austria, Germany, Canada, and Sweden. It is headquartered in Holliston, Massachusetts and employs around 417 people. The company recorded revenues of $108.7 million in the fiscal year ended December 2014, an increase of 3.3% over 2013. The company's operating profit was $6.6 million in fiscal 2014, as compared to an operating profit of $1.5 million in 2013. Its net profit was $2.4 million in fiscal 2014, as compared to the net loss of $1.8 million in 2013. Reasons to Purchase: - Gain understanding of Harvard Bioscience, Inc. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Harvard Bioscience, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Harvard Bioscience, Inc. your competitors' business structure, strategy and prospects